Hemoglobin A1c testing is associated with improved pancreas utilization for transplant.

Context: Aging, higher prevalence of diabetes, worsening obesity, and hyperglycemia among potential donors increase the likelihood that pancreata will be declined by transplant centers. Hemoglobin A1c testing, also known as glycated hemoglobin testing, identifies a donor's average blood glucose concentration for the preceding 2 to 3 months and is the standard test for identifying prolonged periods of hyperglycemia.

Objective: To compare pancreas utilization rates before and after implementation of hemoglobin A1c testing.